Gsa Capital Partners LLP Rockwell Medical, Inc. Transaction History
Gsa Capital Partners LLP
- $1.2 Billion
- Q3 2025
A detailed history of Gsa Capital Partners LLP transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 163,978 shares of RMTI stock, worth $152,499. This represents 0.02% of its overall portfolio holdings.
Number of Shares
163,978
Previous 22,306
635.13%
Holding current value
$152,499
Previous $19,000
936.84%
% of portfolio
0.02%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RMTI
# of Institutions
41Shares Held
3.4MCall Options Held
25.6KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.35MShares$1.26 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny562KShares$522,8500.0% of portfolio
-
Geode Capital Management, LLC Boston, MA323KShares$300,5270.0% of portfolio
-
Black Rock Inc. New York, NY219KShares$203,4100.0% of portfolio
-
State Street Corp Boston, MA101KShares$93,8400.0% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $9.93M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...